Status | Study |
Not yet recruiting |
Study Name: Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery Condition: Metastatic Leiomyosarcoma Metastatic Liposarcoma Date: 2017-03-01 Interventions: Drug: Avelumab Given IV |
Recruiting |
Study Name: A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma Condition: Myxoid Round Cell Liposarcoma High Grade Myxoid Date: 2016-12-12 Interventions: Genetic: Autologous genetically modified T Cells, NY-ESO-1ᶜ²⁵⁹T Cytoreductive che |
Recruiting |
Study Name: MGCD516 in Advanced Liposarcoma and Other Soft Tissue Sarcomas Condition: Liposarcoma Metastatic Liposarcoma Date: 2016-11-29 Interventions: Drug: MGCD516 Administered at 150 mg orally, daily, in continuous 21 day cycles. An orally available, po |
Recruiting |
Study Name: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma Condition: Liposarcomas, Dedifferentiated Liposarcom Date: 2016-11-29 Interventions: Drug: Ribociclib Ribociclib Oral 600 mg x 1 a day 21 days on 1 week off in 28 days cycles |
Recruiting |
Study Name: Study of Abemaciclib in Dedifferentiated Liposarcoma Condition: Sarcoma Dedifferentiated Liposarcoma Date: 2016-07-25 Interventions: Drug: Abemaciclib Other Name: LY2835219 |
Recruiting |
Study Name: Selinexor in Advanced Liposarcoma Condition: Dedifferentiated Liposarcoma Date: 2015-10-13 Interventions: Drug: Selinexor Selinexor 60mg |
Active, not recruiting |
Study Name: A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma Condition: Liposarcoma Soft Tissue Sarcoma Date: 2015-10-06 Interventions: Drug: ribociclib Oral, 600 mg x 1 a day, duration - according to response |
Recruiting |
Study Name: Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma Condition: Liposarcoma Date: 2015-01-05 Interventions: Drug: HDM201 Drug: LEE011 |
Recruiting |
Study Name: Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery Condition: Liposarcoma Date: 2014-09-24 Interventions: Drug: efatutazone Given PO |
Recruiting |
Study Name: Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma Condition: Liposarcoma Leiomyosarcoma Date: 2014-09-05 Interventions: Drug: Trabectedin Trabectedin administered at a dose of 1.5 mg/m2 - 1.3 mg/m2 (at investigator's discret |